Charles River Laboratories said it will close its cell therapy contract development and manufacturing site in Hanover, Md., eliminating 20 positions, according to a state Worker Adjustment and Retraining Notification filing. The closure is part of an ongoing restructuring at the Boston-based contract research organization, which has been reducing headcount and exiting select operations following a strategic review. The company said it determined that the Hanover facility was not a strategic f...